These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2297301)

  • 1. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients.
    Novick DM; Joseph H; Croxson TS; Salsitz EA; Wang G; Richman BL; Poretsky L; Keefe JB; Whimbey E
    Arch Intern Med; 1990 Jan; 150(1):97-9. PubMed ID: 2297301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
    Novick DM; Ochshorn M; Ghali V; Croxson TS; Mercer WD; Chiorazzi N; Kreek MJ
    J Pharmacol Exp Ther; 1989 Aug; 250(2):606-10. PubMed ID: 2788218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis associated with drug abuse: significance of hepatitis B virus.
    Miller DJ; Kleber H; Bloomer JR
    Yale J Biol Med; 1979; 52(1):135-40. PubMed ID: 452620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heroin users seeking methadone treatment.
    Bell J; Fernandes D; Batey R
    Med J Aust; 1990 Apr; 152(7):361-4. PubMed ID: 2093804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immunogenicity of the hepatitis B vaccine in drug addicts with human immunodeficiency virus infection].
    Menicagli V; Barbanera M; Menicagli S
    Recenti Prog Med; 1991 Feb; 82(2):69-71. PubMed ID: 2034870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers.
    De Castro S; Sabaté E
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S464-7. PubMed ID: 14648465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methadone maintenance of HIV-infected drug addicts with immune deficiency].
    Waal H; Knutsen T; Welle-Strand G
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3083-6. PubMed ID: 1658974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor.
    Baklan Z; Gorisek JR; Poljak M; Pisec A
    Wien Klin Wochenschr; 2004; 116 Suppl 2():5-7. PubMed ID: 15506302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
    Dolan KA; Shearer J; White B; Zhou J; Kaldor J; Wodak AD
    Addiction; 2005 Jun; 100(6):820-8. PubMed ID: 15918812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care of parenteral substance abusers.
    Williams A
    Nurse Pract; 1986 Jun; 11(6):17, 20, 25 passim. PubMed ID: 3459065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 25-year follow-up of patients admitted to methadone treatment for the first time: mortality and gender differences.
    Jimenez-Treviño L; Saiz PA; García-Portilla MP; Díaz-Mesa EM; Sánchez-Lasheras F; Burón P; Casares MJ; Marina P; Gutiérrez E; Bobes J
    Addict Behav; 2011 Dec; 36(12):1184-90. PubMed ID: 21835551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B antigen and antibody in former heroin addicts on methadone maintenance: correlation with clinical and histological findings.
    Stimmel B; Vernace S; Heller E; Tobias H
    Proc Natl Conf Methadone Treat; 1973; 1():501-6. PubMed ID: 4808193
    [No Abstract]   [Full Text] [Related]  

  • 16. Pattern of drug abuse and prevalence of antibodies to human immunodeficiency virus in heroin addicts in Jerusalem, 1989.
    Shufman EN; Engelhard D; Bar-El CY; Morag A
    Isr J Med Sci; 1990 Nov; 26(11):616-8. PubMed ID: 2254077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
    Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
    Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug use and HIV/AIDS in China.
    Liu Z; Lian Z; Zhao C
    Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of treatment with methadone on utilization of medical care by addicts seropositive for the AIDS virus. Results of a descriptive study, Bayonne, 1996].
    Lafitte C; Bonnal F; Daulouede JP; Tignol J
    Encephale; 1998; 24(3):205-14. PubMed ID: 9696913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.